PT Siloam International Hospitals Tbk Reg-S
IIDX:SILO1,850.00
IDR
+55.00
(+3.06%)
ISIN
ID1000129208
Return %
Stock
S&P 500
1Y
-2.12
14.20
3Y
-20.26
81.12
5Y
71.10
68.34
Capital Structure
IDR
•
in mil. unless spec.Working Capital
IDR
•
in mil. unless spec.Growth Rates
IDR
•
in mil. unless spec.Quarterly Revenue
IDR
•
in mil. unless spec.Quarterly Earnings Per Share
IDR
•
in mil. unless spec.Quarterly Dividends Per Share
IDR
•
in mil. unless spec.Company Description
- CEO
- David Utama
- Full Time Employees
- 14,872
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Gedung Fakultas Kedokteran Universitas Pelita Harapan (UPH) Tangerang BT Indonesia 15810
- IPO Date
- Sep 12, 2013
- Website
- siloamhospitals.com
- Similar Companies
- Business
- PT Siloam International Hospitals Tbk (SILO.JK) operates Indonesia's largest private hospital network, providing comprehensive healthcare services including specialized medical treatments, diagnostic imaging, laboratory testing, radiation therapy, emergency care, surgical procedures across multiple disciplines such as cardiology, oncology, neurology, orthopedics, obstetrics, pulmonology, and urology; general, pre-marital, heart, kidney, cancer, and visa medical check-ups; teleconsultation, home healthcare, genomic testing, and vaccination services; as well as advanced interventions like transplantation, gamma knife surgery, and brainstem surgery. The company manages over 41 hospitals and 25 clinics equipped with state-of-the-art facilities and staffed by specialists and sub-specialists, serving patients across diverse socio-economic backgrounds with a focus on accessibility and quality care. Founded in 1996 and headquartered in Tangerang, Banten, Indonesia, in the Pelita Harapan University Medical Faculty Building, Siloam extends its operations nationwide across Java, Sumatra, Bali, Kalimantan, Sulawesi, Nusa Tenggara Timur, Nusa Tenggara Barat, and Bangka Belitung, targeting individual patients, corporate clients, and government programs in the healthcare facilities and services sector. In recent developments, CVC Capital Partners acquired a controlling stake exceeding US$1 billion from PT Lippo Karawaci Tbk in 2024, establishing a joint venture structure while Lippo retains a minority interest, followed by Sight Investment Company Pte. Limited increasing its ownership to 63% through the purchase of 1.04 billion shares in December 2024. In January 2025, Marubeni Corporation signed a Memorandum of Strategic Partnership to deepen collaboration, including joint ventures in outsourcing services like laboratory testing and specialized hospitals, building on Marubeni's 2020 equity investment. The company continues expansion with new facilities such as Siloam Clinic Soe in East Nusa Tenggara in late 2023 and fertility clinic services at Siloam Hospitals Lippo Village, alongside ongoing programs like SELANGKAH breast cancer screening and uro-nephrology symposia to enhance medical expertise. Siloam, a subsidiary of Sight Investment Company Pte. Limited, maintains strategic ties with Lippo Group entities and reported nine-month earnings through September 30, 2025, underscoring its growth amid Indonesia's rising healthcare demands.